Artificial intelligence does not add a pillar to corporate governance. It tests each of the five the board already holds, and the minutes are the evidence of how the board responded.

A board's scarcest asset is its attention. Avancer's heat map rates twelve board duties by AI impact for health systems, medical device and diagnostics companies, pharmaceutical and biotechnology companies, and health plans, adjusts two duties for public companies, and shows how the ratings set the agenda.